[Multimodal interventional therapy of a large renal cell carcinoma in a patient with high anesthesia risk - a case report].
G
G
Brinkhaus
P
P
Wust
B
B
Gebauer
D000768:Anesthesia, General; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001707:Biopsy, Needle; D001918:Brachytherapy; D002292:Carcinoma, Renal Cell / Q000098:blood supply / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D017115:Catheter Ablation; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D016292:Procedural Sedation; D000075202:Contraindications; D004621:Embolization, Therapeutic; D005500:Follow-Up Studies; D006305:Health Status Indicators; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007211:Indoles / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology / Q000601:surgery; D007680:Kidney Neoplasms / Q000098:blood supply / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D008207:Lymphatic Metastasis / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D009367:Neoplasm Staging; D011656:Pulmonary Emphysema / Q000150:complications; D011758:Pyrroles / Q000627:therapeutic use; D015642:Radiology, Interventional; D018714:Radiotherapy, Adjuvant; D012131:Respiratory Insufficiency / Q000150:complications; D000077210:Sunitinib; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib